Scientists of the Russian Academy of medical Sciences has created a drug that prevents the destruction of nerve cells. This drug can be a drug for the treatment of Parkinson's disease, stroke, Alzheimer's disease, and depression.
These pills contain modified amino acid molecules, and at the moment the drug are in the process of pre-clinical trials. This drug has already proved its efficiency during system introduction mammals. This know-how in the field of pharmacy has already received a patent in Russia, and is in a similar process in the United States, China and India, according to the newspaper "Izvestia".
Alzheimer's and Parkinson's, as well as hemorrhagic and ischemic strokes are associated directly with the active protein NGF and BDNF protects neurons in the brain. Prevention of Parkinson's disease and Alzheimer's, as well as the influence on the process of stroke is carried out by simulating the drug of nerve growth factor BDNF and NGF.
The complexity of the treatment of these diseases is the inability of large proteins in overcoming the blood-brain barrier brain. With this purpose, scientists have created small molecules that mimic the properties of large proteins.
Up until the new drug will not pass all the necessary research and tests, the authors medications insist that its significance was not exaggerated.